Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
Jaekyung CheonYoo Jin LeeJae-Cheol JoKukju KweonSuJin KohYoung Ju MinSang-Hyuk ParkSin-Hye LeeHyo-Jin KimYun Suk ChoiPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
Younger patients (< 60 years), female, ALL, chronic GVHD, and continuous immunosuppressant use were significant risk factors for worse QOL and depression. Hence, creating a more active survivorship care plan after HSCT, specifically for these patients, is required.
Keyphrases
- end stage renal disease
- allogeneic hematopoietic stem cell transplantation
- chronic kidney disease
- ejection fraction
- newly diagnosed
- prognostic factors
- acute myeloid leukemia
- peritoneal dialysis
- acute lymphoblastic leukemia
- palliative care
- physical activity
- risk factors
- patient reported outcomes
- quality improvement
- patient reported
- affordable care act